The EIF2AK1 Knockout A-549 Polyclonal Cells represent a polyclonal population of human A-549 lung adenocarcinoma cells engineered via CRISPR/Cas9-mediated gene disruption to ablate functional expression of the EIF2AK1 gene. This pooled polyclonal format provides a heterogeneous knockout cell population suitable for studying EIF2AK1-dependent stress signaling in a cellular context that preserves the genetic and phenotypic diversity inherent to polyclonal editing. The product serves as a robust loss-of-function model for investigating the integrated stress response (ISR) without relying on pharmacological inhibition or RNA interference, enabling sustained knockout in a well-characterized cancer cell background.
The A-549 host cell line was originally derived from a lung carcinoma of a 58-year-old Caucasian male and exhibits an adherent epithelial morphology. These cells are widely recognized as a model for type II pulmonary epithelial cells and are extensively employed in respiratory infection studies, lung adenocarcinoma research, and cancer biology. Their epithelial origin and tumorigenic properties make them a relevant platform for examining stress-responsive signaling pathways that influence tumor cell survival, proliferation, and adaptation to microenvironmental insults.
EIF2AK1, or heme-regulated inhibitor (HRI), is a kinase central to the integrated stress response (ISR). It is activated by heme deficiency, oxidative stress (H?O?, arsenite), heat shock, osmotic stress, nitric oxide, proteasome inhibition, and Hsp90 disruption. Upon activation, EIF2AK1 phosphorylates eIF2?? (EIF2S1) to suppress global translation while stimulating selective translation of ATF4, which in turn upregulates DDIT3 (CHOP) and PPP1R15A (GADD34) to govern cell fate. EIF2AK1 functions alongside EIF2AK2 (PKR), EIF2AK3 (PERK), and EIF2AK4 (GCN2), all converging on eIF2?? to integrate diverse stress inputs. Its activity is modulated by interactions with heme and Hsp90, linking heme metabolism directly to translational control.
Within the A-549 lung adenocarcinoma model, EIF2AK1 knockout enables dissection of heme-regulated translational control in cancer cell stress adaptation. Lung tumor cells experience oxidative and metabolic stress, making the ISR a key modulator of therapeutic resistance. Ablation of EIF2AK1 allows investigation of phospho-eIF2?? signaling, ATF4/CHOP induction, stress granule formation, and cell survival under heme deprivation or oxidative stress. This model is valuable for probing EIF2AK1’s role in apoptosis evasion and metabolic reprogramming frequently observed in solid tumors.
Applications include mechanistic ISR studies in lung adenocarcinoma, screening of HRI kinase inhibitors, analysis of stress granule dynamics and translational control, and modeling of anemia-linked stress signaling. Compatible assays comprise western blotting for phospho-eIF2?? and ATF4, RT-qPCR for ATF4 and DDIT3 mRNA, immunofluorescence for stress granules, viability assays under oxidative stress, polysome profiling, and phospho-signaling arrays. For additional details or custom requests, please contact Ascent Research.
